FDA Import Refusal SCS-9849957-9/11/1 — Centurion Laboratories
The FDA refused shipment SCS-9849957-9/11/1 from Centurion Laboratories (India) on Mar 10, 2022. The refused product falls under Drugs and Biologics — TADALAFIL. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 10, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66SCY51 TADALAFIL
- Charges
- 75